Published in Pharma Investments, Ventures and Law Weekly, November 20th, 2005
AngioDynamics and Vascular Solutions market endovenous laser ablation products for use in procedures that VNUS believes infringe several of its patents. VNUS is seeking an injunction prohibiting AngioDynamics and Vascular Solutions from selling these products, in addition to monetary damages. These claims were added to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.